{"id": "article-28807_0", "title": "Sebaceous Gland Carcinoma -- Continuing Education Activity", "content": "Sebaceous carcinomas are rare malignant tumors of the sebaceous glands. They most commonly develop on the eyelid, but may arise from anywhere sebaceous glands are present. These tumors may arise spontaneously or in association with Muir-Torre syndrome. This activity reviews the diagnosis, evaluation, and treatment of sebaceous carcinomas and highlights the role of the interprofessional team in evaluating and treating patients with this condition.", "contents": "Sebaceous Gland Carcinoma -- Continuing Education Activity. Sebaceous carcinomas are rare malignant tumors of the sebaceous glands. They most commonly develop on the eyelid, but may arise from anywhere sebaceous glands are present. These tumors may arise spontaneously or in association with Muir-Torre syndrome. This activity reviews the diagnosis, evaluation, and treatment of sebaceous carcinomas and highlights the role of the interprofessional team in evaluating and treating patients with this condition."}
{"id": "article-28807_1", "title": "Sebaceous Gland Carcinoma -- Continuing Education Activity", "content": "Objectives: Identify the etiology of sebaceous carcinomas. Review the process for the evaluation of sebaceous carcinomas. Outline the management options available for sebaceous carcinomas. Describe interprofessional team strategies for improving care coordination and communication to advance sebaceous carcinoma treatment and improve outcomes. Access free multiple choice questions on this topic.", "contents": "Sebaceous Gland Carcinoma -- Continuing Education Activity. Objectives: Identify the etiology of sebaceous carcinomas. Review the process for the evaluation of sebaceous carcinomas. Outline the management options available for sebaceous carcinomas. Describe interprofessional team strategies for improving care coordination and communication to advance sebaceous carcinoma treatment and improve outcomes. Access free multiple choice questions on this topic."}
{"id": "article-28807_2", "title": "Sebaceous Gland Carcinoma -- Introduction", "content": "Sebaceous carcinoma (SC) is a rare and aggressive malignancy that develops from the sebaceous glands. Sebaceous carcinoma is most common in the periocular area, head, and neck, but can occur anywhere in the body where sebaceous glands are present. [1]", "contents": "Sebaceous Gland Carcinoma -- Introduction. Sebaceous carcinoma (SC) is a rare and aggressive malignancy that develops from the sebaceous glands. Sebaceous carcinoma is most common in the periocular area, head, and neck, but can occur anywhere in the body where sebaceous glands are present. [1]"}
{"id": "article-28807_3", "title": "Sebaceous Gland Carcinoma -- Introduction", "content": "Sebaceous carcinomas may behave as primary neoplasms\u00a0or may\u00a0occur in association with Muir-Torre syndrome (a form of Lynch syndrome\u00a0characterized by sebaceous tumors and other\u00a0internal cancers, being the most common those affecting the\u00a0gastrointestinal tract). SC behaves aggressively both locally and distantly; locally, it correlates with a multifocal origin, and causes destruction and sometimes a pattern of pagetoid spread, which is challenging to diagnose. Moreover, this tumor easily causes distant metastasis. For those reasons, the SC is considered an aggressive disease, which causes significant morbidity and mortality.", "contents": "Sebaceous Gland Carcinoma -- Introduction. Sebaceous carcinomas may behave as primary neoplasms\u00a0or may\u00a0occur in association with Muir-Torre syndrome (a form of Lynch syndrome\u00a0characterized by sebaceous tumors and other\u00a0internal cancers, being the most common those affecting the\u00a0gastrointestinal tract). SC behaves aggressively both locally and distantly; locally, it correlates with a multifocal origin, and causes destruction and sometimes a pattern of pagetoid spread, which is challenging to diagnose. Moreover, this tumor easily causes distant metastasis. For those reasons, the SC is considered an aggressive disease, which causes significant morbidity and mortality."}
{"id": "article-28807_4", "title": "Sebaceous Gland Carcinoma -- Etiology", "content": "As mentioned above, SC has its origin in sebaceous cells. When occurring in the periocular region, the most frequent, SC\u00a0usually arise from Meibomian glands, which are modified sebaceous glands, but also from the sebaceous glands of Zeiss, and the sebaceous glands\u00a0in the ocular caruncle. [2]", "contents": "Sebaceous Gland Carcinoma -- Etiology. As mentioned above, SC has its origin in sebaceous cells. When occurring in the periocular region, the most frequent, SC\u00a0usually arise from Meibomian glands, which are modified sebaceous glands, but also from the sebaceous glands of Zeiss, and the sebaceous glands\u00a0in the ocular caruncle. [2]"}
{"id": "article-28807_5", "title": "Sebaceous Gland Carcinoma -- Etiology", "content": "The majority of sebaceous carcinomas arise from de novo mutations. They may also develop from benign sebaceous neoplasms, although this appears to be relatively uncommon. Sebaceous carcinomas associated with Muir-Torre syndrome have a loss of mismatch repair gene expression and exhibit microsatellite instability. [3] Sebaceous carcinomas that occur sporadically do not exhibit loss of mismatch repair or microsatellite instability. [4]", "contents": "Sebaceous Gland Carcinoma -- Etiology. The majority of sebaceous carcinomas arise from de novo mutations. They may also develop from benign sebaceous neoplasms, although this appears to be relatively uncommon. Sebaceous carcinomas associated with Muir-Torre syndrome have a loss of mismatch repair gene expression and exhibit microsatellite instability. [3] Sebaceous carcinomas that occur sporadically do not exhibit loss of mismatch repair or microsatellite instability. [4]"}
{"id": "article-28807_6", "title": "Sebaceous Gland Carcinoma -- Epidemiology", "content": "SC is more frequent in older women. It is a rare malignancy in White race individuals, whereas in the Asian population represents up to 28% of all lid malignancies. Overall, SC\u00a0has an estimated incidence of approximately 1\u00a0to 2 cases per 1,000,000 person-years. [5] [6] More than 98% of SC\u00a0occurs in patients over the age of 40, and the peak incidence occurs in the seventh and eighth decades of life. [7] There\u00a0have only been reports of it appearing in a handful of childhood cases. [8] Sebaceous carcinoma is approximately three times as common in whites as in non-White patients. Regarding the anatomy, these tumors are more frequent in the upper eyelid, as there are more meibomian glands there. [9] [7] Risk factors for the development of sebaceous carcinoma include prior radiation exposure, immunosuppression, and Muir-Torre syndrome.", "contents": "Sebaceous Gland Carcinoma -- Epidemiology. SC is more frequent in older women. It is a rare malignancy in White race individuals, whereas in the Asian population represents up to 28% of all lid malignancies. Overall, SC\u00a0has an estimated incidence of approximately 1\u00a0to 2 cases per 1,000,000 person-years. [5] [6] More than 98% of SC\u00a0occurs in patients over the age of 40, and the peak incidence occurs in the seventh and eighth decades of life. [7] There\u00a0have only been reports of it appearing in a handful of childhood cases. [8] Sebaceous carcinoma is approximately three times as common in whites as in non-White patients. Regarding the anatomy, these tumors are more frequent in the upper eyelid, as there are more meibomian glands there. [9] [7] Risk factors for the development of sebaceous carcinoma include prior radiation exposure, immunosuppression, and Muir-Torre syndrome."}
{"id": "article-28807_7", "title": "Sebaceous Gland Carcinoma -- Histopathology", "content": "Histopathology typically shows irregular, asymmetric sebaceous lobules within the dermis. Malignant cells show significant amounts of pleomorphism, hyperchromatism, mitotic activity, and nuclear atypia. Lesions may be classified as poorly, moderately, or well-differentiated (see Images. Sebaceous Carcinoma, Low-Power Field; Sebaceous Carcinoma, High-Power Field). Well-differentiated lesions may demonstrate foamy cytoplasm, comedo-necrosis, and pagetoid spread. [10] Sebaceous carcinomas fall into four histopathologic categories: papillary, lobular, comedocarcinoma, and mixed. [11] Immunohistochemical stains for sebaceous carcinoma include adipophilin, EMA, androgen receptor, and nuclear factor XIIIa. [12] [13] Adipophilin in a vesicular instead of granular staining pattern and nuclear factor XIIIa are the most specific and sensitive among the stains. [13] [14] [15] Negative staining for S100 and HMB-45 may help differentiate sebaceous carcinoma from balloon cell or amelanotic melanoma. [10]", "contents": "Sebaceous Gland Carcinoma -- Histopathology. Histopathology typically shows irregular, asymmetric sebaceous lobules within the dermis. Malignant cells show significant amounts of pleomorphism, hyperchromatism, mitotic activity, and nuclear atypia. Lesions may be classified as poorly, moderately, or well-differentiated (see Images. Sebaceous Carcinoma, Low-Power Field; Sebaceous Carcinoma, High-Power Field). Well-differentiated lesions may demonstrate foamy cytoplasm, comedo-necrosis, and pagetoid spread. [10] Sebaceous carcinomas fall into four histopathologic categories: papillary, lobular, comedocarcinoma, and mixed. [11] Immunohistochemical stains for sebaceous carcinoma include adipophilin, EMA, androgen receptor, and nuclear factor XIIIa. [12] [13] Adipophilin in a vesicular instead of granular staining pattern and nuclear factor XIIIa are the most specific and sensitive among the stains. [13] [14] [15] Negative staining for S100 and HMB-45 may help differentiate sebaceous carcinoma from balloon cell or amelanotic melanoma. [10]"}
{"id": "article-28807_8", "title": "Sebaceous Gland Carcinoma -- History and Physical", "content": "Approximately 40% of all sebaceous carcinomas present on the eyelids, with 80% occurring on the head or neck. [1] On the eyelid, sebaceous carcinomas typically develop as a firm, round, enlarging nodule. They are two to three times more frequent in the upper lid due to the more number of sebaceous glands there. SC\u00a0may also present with inflammation and thickening of the eyelid, typically mimicking other conditions, especially chalazion and blepharitis, and even conjunctivitis, and causing a delayed diagnosis. Local spread is frequent and may lead to involve wide areas of the conjunctiva and even the cornea. Advanced infiltration may cause\u00a0invasion of the orbit and adjacent periorbital structures.", "contents": "Sebaceous Gland Carcinoma -- History and Physical. Approximately 40% of all sebaceous carcinomas present on the eyelids, with 80% occurring on the head or neck. [1] On the eyelid, sebaceous carcinomas typically develop as a firm, round, enlarging nodule. They are two to three times more frequent in the upper lid due to the more number of sebaceous glands there. SC\u00a0may also present with inflammation and thickening of the eyelid, typically mimicking other conditions, especially chalazion and blepharitis, and even conjunctivitis, and causing a delayed diagnosis. Local spread is frequent and may lead to involve wide areas of the conjunctiva and even the cornea. Advanced infiltration may cause\u00a0invasion of the orbit and adjacent periorbital structures."}
{"id": "article-28807_9", "title": "Sebaceous Gland Carcinoma -- History and Physical", "content": "SC\u00a0of extra-ocular locations generally presents as a yellowish nodule, often with ulceration. The head and neck are the most common locations; however, the trunk and extremities may also have involvement. There are also rare reports of cases of SC\u00a0development at extracutaneous sites, such as the parotid gland, breast, ovary, and prostate. [16]", "contents": "Sebaceous Gland Carcinoma -- History and Physical. SC\u00a0of extra-ocular locations generally presents as a yellowish nodule, often with ulceration. The head and neck are the most common locations; however, the trunk and extremities may also have involvement. There are also rare reports of cases of SC\u00a0development at extracutaneous sites, such as the parotid gland, breast, ovary, and prostate. [16]"}
{"id": "article-28807_10", "title": "Sebaceous Gland Carcinoma -- Evaluation", "content": "SC must always be in mind when treating a patient with unilateral resistant blepharoconjunctivitis, or a chalazion or stye that does not resolve or recur after treatment. An incisional biopsy might be necessary to confirm the diagnosis. Excisional biopsy with wide margins is considered the gold standard treatment, which is also useful to confirm the diagnosis. Routine histologic staining with hematoxylin and eosin will generally provide a diagnosis and is useful for staging of the lesion. Immunohistochemistry may also be useful to confirm the diagnosis and to differentiate from other non-melanoma skin cancers. Sebaceous carcinomas can exhibit nearly 100% EMA, ADP, and AR positivity. [12] [14] [17] While the majority of sebaceous carcinomas occur sporadically, some\u00a0experts recommend screening all patients with this diagnosis for Muir-Torre syndrome.", "contents": "Sebaceous Gland Carcinoma -- Evaluation. SC must always be in mind when treating a patient with unilateral resistant blepharoconjunctivitis, or a chalazion or stye that does not resolve or recur after treatment. An incisional biopsy might be necessary to confirm the diagnosis. Excisional biopsy with wide margins is considered the gold standard treatment, which is also useful to confirm the diagnosis. Routine histologic staining with hematoxylin and eosin will generally provide a diagnosis and is useful for staging of the lesion. Immunohistochemistry may also be useful to confirm the diagnosis and to differentiate from other non-melanoma skin cancers. Sebaceous carcinomas can exhibit nearly 100% EMA, ADP, and AR positivity. [12] [14] [17] While the majority of sebaceous carcinomas occur sporadically, some\u00a0experts recommend screening all patients with this diagnosis for Muir-Torre syndrome."}
{"id": "article-28807_11", "title": "Sebaceous Gland Carcinoma -- Evaluation", "content": "A comprehensive physical exam to assess the globe and the periocular region for disease, as well as palpation of the preauricular and cervical areas for enlarged lymph nodes, should be performed. If the eyelid lesion appears to be diffuse or if there is any evidence of lymphadenopathy, then head and neck\u00a0or even systemic imaging are warranted to evaluate the degree of\u00a0disease spread. Fine-needle aspiration biopsy of suspicious lymph nodes can help diagnose sebaceous carcinoma.", "contents": "Sebaceous Gland Carcinoma -- Evaluation. A comprehensive physical exam to assess the globe and the periocular region for disease, as well as palpation of the preauricular and cervical areas for enlarged lymph nodes, should be performed. If the eyelid lesion appears to be diffuse or if there is any evidence of lymphadenopathy, then head and neck\u00a0or even systemic imaging are warranted to evaluate the degree of\u00a0disease spread. Fine-needle aspiration biopsy of suspicious lymph nodes can help diagnose sebaceous carcinoma."}
{"id": "article-28807_12", "title": "Sebaceous Gland Carcinoma -- Treatment / Management", "content": "The primary goal of treatment is complete surgical excision of the tumor. Wide local excision with the use of frozen sections, or Mohs micrographic surgery, are first-line treatments for sebaceous carcinoma of the head or neck. [18] [1] If conjunctival epithelial involvement is identified, treatment may involve cryotherapy, surgical resection of the affected bulbar epithelium, or use of topical mitomycin C. [19] In cases where surgical resection is not possible, mainly in cases of extensive conjunctival spread or orbital extension, orbital exenteration is often required.", "contents": "Sebaceous Gland Carcinoma -- Treatment / Management. The primary goal of treatment is complete surgical excision of the tumor. Wide local excision with the use of frozen sections, or Mohs micrographic surgery, are first-line treatments for sebaceous carcinoma of the head or neck. [18] [1] If conjunctival epithelial involvement is identified, treatment may involve cryotherapy, surgical resection of the affected bulbar epithelium, or use of topical mitomycin C. [19] In cases where surgical resection is not possible, mainly in cases of extensive conjunctival spread or orbital extension, orbital exenteration is often required."}
{"id": "article-28807_13", "title": "Sebaceous Gland Carcinoma -- Treatment / Management", "content": "The role of radiation therapy for primary sebaceous carcinomas is uncertain.\u00a0Some small studies have reported good outcomes from the use of radiation as the primary treatment of ocular sebaceous carcinoma, but surgical resection remains the primary treatment modality. [20] [21] Adjuvant therapies include cryotherapy, and topical mitomycin C. The use of these therapies is primarily reserved for pagetoid spread to the conjunctiva.", "contents": "Sebaceous Gland Carcinoma -- Treatment / Management. The role of radiation therapy for primary sebaceous carcinomas is uncertain.\u00a0Some small studies have reported good outcomes from the use of radiation as the primary treatment of ocular sebaceous carcinoma, but surgical resection remains the primary treatment modality. [20] [21] Adjuvant therapies include cryotherapy, and topical mitomycin C. The use of these therapies is primarily reserved for pagetoid spread to the conjunctiva."}
{"id": "article-28807_14", "title": "Sebaceous Gland Carcinoma -- Differential Diagnosis", "content": "Several benign and malignant conditions merit consideration in the differential diagnosis for SC. These tumors\u00a0may often mimic a chalazion, especially if they become painful or inflamed, resistant to the usual treatment, or if they recur after surgery. An extensive list of eyelid masses may be part of the differential diagnosis of SC, including apart from the most frequent chalazion, other tumors such us inclusion cyst, papilloma, keratosis, keratoacanthoma, or dermoid cyst, among others. [22]", "contents": "Sebaceous Gland Carcinoma -- Differential Diagnosis. Several benign and malignant conditions merit consideration in the differential diagnosis for SC. These tumors\u00a0may often mimic a chalazion, especially if they become painful or inflamed, resistant to the usual treatment, or if they recur after surgery. An extensive list of eyelid masses may be part of the differential diagnosis of SC, including apart from the most frequent chalazion, other tumors such us inclusion cyst, papilloma, keratosis, keratoacanthoma, or dermoid cyst, among others. [22]"}
{"id": "article-28807_15", "title": "Sebaceous Gland Carcinoma -- Differential Diagnosis", "content": "Benign sebaceous neoplasms such as sebaceous adenomas may present similarly to SC, but these benign lesions are uncommon in the periocular region. [23] Basal cell carcinomas, squamous cell carcinomas, and Merkel cell carcinomas may all have clinical presentations similar to SC; the histologic examination is essential for differentiating these.", "contents": "Sebaceous Gland Carcinoma -- Differential Diagnosis. Benign sebaceous neoplasms such as sebaceous adenomas may present similarly to SC, but these benign lesions are uncommon in the periocular region. [23] Basal cell carcinomas, squamous cell carcinomas, and Merkel cell carcinomas may all have clinical presentations similar to SC; the histologic examination is essential for differentiating these."}
{"id": "article-28807_16", "title": "Sebaceous Gland Carcinoma -- Staging", "content": "Evaluation for evidence of local tumor spread should be performed immediately after diagnosis. Regional lymph nodes should be palpated for evidence of metastasis, with a biopsy performed on concerning lymph nodes. Ophthalmologists usually diagnose patients diagnosed with SC of the eyelids; a comprehensive ophthalmic examination is mandatory to assess for the clinical tumor extension.", "contents": "Sebaceous Gland Carcinoma -- Staging. Evaluation for evidence of local tumor spread should be performed immediately after diagnosis. Regional lymph nodes should be palpated for evidence of metastasis, with a biopsy performed on concerning lymph nodes. Ophthalmologists usually diagnose patients diagnosed with SC of the eyelids; a comprehensive ophthalmic examination is mandatory to assess for the clinical tumor extension."}
{"id": "article-28807_17", "title": "Sebaceous Gland Carcinoma -- Staging", "content": "There is no clear consensus and guidelines concerning the systemic evaluation of these patients; however, patients with large tumors, or those where there has been delayed diagnosis, should undergo imaging with CT or MRI to evaluate for a distant extension. Patients with Muir-Torre may also receive benefits from a PET scan for early detection of visceral malignancies. [24]", "contents": "Sebaceous Gland Carcinoma -- Staging. There is no clear consensus and guidelines concerning the systemic evaluation of these patients; however, patients with large tumors, or those where there has been delayed diagnosis, should undergo imaging with CT or MRI to evaluate for a distant extension. Patients with Muir-Torre may also receive benefits from a PET scan for early detection of visceral malignancies. [24]"}
{"id": "article-28807_18", "title": "Sebaceous Gland Carcinoma -- Prognosis", "content": "Sebaceous carcinomas tend to be aggressive with significant potential for nodal and distant metastasis. Ocular sebaceous carcinomas have demonstrated a recurrence rate of 11\u00a0to 30% after excision and a rate of metastasis of 25%. [25] For extraocular sebaceous carcinoma, rates of recurrence and distant metastases are 29% and 21%, respectively. [1]", "contents": "Sebaceous Gland Carcinoma -- Prognosis. Sebaceous carcinomas tend to be aggressive with significant potential for nodal and distant metastasis. Ocular sebaceous carcinomas have demonstrated a recurrence rate of 11\u00a0to 30% after excision and a rate of metastasis of 25%. [25] For extraocular sebaceous carcinoma, rates of recurrence and distant metastases are 29% and 21%, respectively. [1]"}
{"id": "article-28807_19", "title": "Sebaceous Gland Carcinoma -- Prognosis", "content": "Regional lymph nodes are the most common sites of spread; lungs, brain, liver, small intestine, and urinary tract metastasis have also been reported. Overall mortality rates are between 9 and 50%. [1] Five-year survival rates are more favorable for the ocular disease at 75.2%, compared to the extraocular disease at 68%. [26] Negative prognostic factors include size greater than 1 cm, poor differentiation on histopathology, lymphovascular invasion, and lesions involving both the upper and lower eyelid.", "contents": "Sebaceous Gland Carcinoma -- Prognosis. Regional lymph nodes are the most common sites of spread; lungs, brain, liver, small intestine, and urinary tract metastasis have also been reported. Overall mortality rates are between 9 and 50%. [1] Five-year survival rates are more favorable for the ocular disease at 75.2%, compared to the extraocular disease at 68%. [26] Negative prognostic factors include size greater than 1 cm, poor differentiation on histopathology, lymphovascular invasion, and lesions involving both the upper and lower eyelid."}
{"id": "article-28807_20", "title": "Sebaceous Gland Carcinoma -- Complications", "content": "Recurrence, local invasion, and distant metastasis by lymphatic or hematogenous spread are all relatively common complications of sebaceous carcinoma.", "contents": "Sebaceous Gland Carcinoma -- Complications. Recurrence, local invasion, and distant metastasis by lymphatic or hematogenous spread are all relatively common complications of sebaceous carcinoma."}
{"id": "article-28807_21", "title": "Sebaceous Gland Carcinoma -- Deterrence and Patient Education", "content": "No known modifiable risk factors for the development of sebaceous carcinoma exist. Patients with a diagnosis of Muir-Torre should receive education regarding the risk of sebaceous carcinoma, and to seek medical care if a concerning skin lesion develops. Also, patients with chronic inflammatory processes of the eye and eyelids should attend an ophthalmologist for an examination.", "contents": "Sebaceous Gland Carcinoma -- Deterrence and Patient Education. No known modifiable risk factors for the development of sebaceous carcinoma exist. Patients with a diagnosis of Muir-Torre should receive education regarding the risk of sebaceous carcinoma, and to seek medical care if a concerning skin lesion develops. Also, patients with chronic inflammatory processes of the eye and eyelids should attend an ophthalmologist for an examination."}
{"id": "article-28807_22", "title": "Sebaceous Gland Carcinoma -- Enhancing Healthcare Team Outcomes", "content": "Sebaceous gland carcinoma is a rare tumor that masquerades as benign ocular conditions and hence requires the clinicians to work in a multidisciplinary team to identify the tumor, make a correct pathological diagnosis, and perform an\u00a0early surgical therapy trying to cure the disease. Delayed management of these cases might be fatal due to the aggressive nature of the tumor. Whenever sebaceous tumors are identified, clinicians should consider internal malignancies.", "contents": "Sebaceous Gland Carcinoma -- Enhancing Healthcare Team Outcomes. Sebaceous gland carcinoma is a rare tumor that masquerades as benign ocular conditions and hence requires the clinicians to work in a multidisciplinary team to identify the tumor, make a correct pathological diagnosis, and perform an\u00a0early surgical therapy trying to cure the disease. Delayed management of these cases might be fatal due to the aggressive nature of the tumor. Whenever sebaceous tumors are identified, clinicians should consider internal malignancies."}
{"id": "article-28807_23", "title": "Sebaceous Gland Carcinoma -- Enhancing Healthcare Team Outcomes", "content": "Early recognition aids in the prompt treatment of patients and screening of family members for early intervention. Many health professionals may be involved in the care of patients affected with SC, such as physicians\u00a0and surgeons of different specialties (depending on the location of the tumor), radiologists, pathologists, and nurses. Disclosure: The views expressed in this article are those of the author and do not reflect the official policy of the Departments of Navy/ Army/ or Air Force, Department of Defense, or US Government.", "contents": "Sebaceous Gland Carcinoma -- Enhancing Healthcare Team Outcomes. Early recognition aids in the prompt treatment of patients and screening of family members for early intervention. Many health professionals may be involved in the care of patients affected with SC, such as physicians\u00a0and surgeons of different specialties (depending on the location of the tumor), radiologists, pathologists, and nurses. Disclosure: The views expressed in this article are those of the author and do not reflect the official policy of the Departments of Navy/ Army/ or Air Force, Department of Defense, or US Government."}
{"id": "article-28807_24", "title": "Sebaceous Gland Carcinoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Sebaceous Gland Carcinoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}